Biotechnology
GV Innovation High-Value Niche Market Transformation Project
TORONTO, May 29, 2024 /PRNewswire/ -- GV has recently undergone a successful transformation, emerging as a high-growth company with world-class high-tech capabilities and an outstanding technical team. The company now holds over 150 independent high-tech research and development patents, with pro...
2024-05-29 20:30
2620
HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max
SHANGHAI and REDWOOD CITY, Calif. , May 29, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation ("Synthego"), a leading provider of innovative CRISPR solutions for de...
2024-05-29 19:30
2062
Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024
* Veritas will present two pioneering studies at the European Society of Human Genetics Conference, inBerlin from June 1 to June 4. With a focus on elective genomic screening and newborn genomic screening, Veritas aims to set new standards in preventive medicine. * The Conference, now in its...
2024-05-29 17:55
1900
Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024
SEOUL, South Korea and WASHINGTON, May 29, 2024 /PRNewswire/ -- Onconic Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for oncology and gastrointestinal disorders, announced today the results of its Phase 3 ZERO-1 study of JAQBO (zastaprazan...
2024-05-29 17:35
2235
Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics
SHANGHAI, May 29, 2024 /PRNewswire/ -- Recently, Frost & Sullivan released the report "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics". I. CDMOs are advancing the biopharmaceutical industry with superior biomanufacturing capabilities...
2024-05-29 14:08
1771
Spectacular advances creating a revolution in the diagnosis and treatment of male infertility
MANILA, Philippines, May 29, 2024 /PRNewswire/ -- Spectacular advances in the diagnosis and treatment of male infertility are offering new hope to the one in six couples globally who seek assisted reproduction to achieve their dreams of parenthood. A major conference on human reproduction in t...
2024-05-29 12:42
1567
US-Based Neurobiotic Leader Bened Life Launches Global Expansion with Neuralli™ MP
FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life
2024-05-29 10:00
1842
US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP
FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life
2024-05-29 10:00
2453
TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE
- Treefrog will present two posters on their cell therapy program in
Parkinson's Disease and their proprietary encapsulation technology, C-Stem™ -
BORDEAUX, France, May 29, 2024 /PRNewswire/ -- TreeFrog Therapeutics
2024-05-29 06:00
1483
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor
SAN DIEGO, May 28, 2024 /PRNewswire/ -- GC Cell
2024-05-28 23:00
1472
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
KYOTO, Japan, May 28, 2024 /PRNewswire/ -- Rege Nephro CO., Ltd. (
https://www.regenephro.co.jp/en
2024-05-28 23:00
1900
Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects
MORRISVILLE, N.C., May 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the availability of spectral data fil...
2024-05-28 21:00
1380
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
* Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. * Collaboration aims to leverage HanAll's extensive expertise in ophthalmic and otic diseases and Turn Bio's cellular reprogramming technology to create innova...
2024-05-28 19:00
1469
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies
* Synergistic collaboration to revolutionize age-related therapies worldwide * Deal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an e...
2024-05-28 19:00
1352
Stavian Chemical Ranks 17th in ICIS Top 100, Signaling Strong Growth Amid Global Market Challenges
HANOI, Vietnam, May 28, 2024 /PRNewswire/ -- Stavian Chemical, a leading global chemical distributor headquartered inVietnam, proudly announces its exceptional performance in the prestigiousICIS Top 100 Chemical Distributors for 2024. Demonstrating the company's robust growth and resilience in th...
2024-05-28 10:00
2529
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA
SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2024-05-28 08:00
2579
Telix Submits NDA for New Prostate Cancer Imaging Agent
MELBOURNE, Australia, May 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for th...
2024-05-27 07:21
1909
Critical need for doctors to counsel couples on potential genetic burden in offspring of older dads
MANILA, Philippines, May 26, 2024 /PRNewswire/ -- An increasing trend of older fatherhood is potentially creating a global genetic disaster with devastating health consequences for offspring. A major conference of human reproductive health in the Philippines will hear of mounting evidence that...
2024-05-26 15:59
2665
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual Meeting
SHANGHAI, May 24, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest progress of the Phase I/II clinical study of 9MW2821, a novel Nectin-4-targeting ADC for multiple advanced solid tumors, which will be reported as an oral pre...
2024-05-24 22:00
5319
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
SHANGHAI, May 24, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced latest clinical research results on GC203 (a novel non-viral vector gene-modif...
2024-05-24 20:00
4253
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
